Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data – The Lancet Commentaries: More side effects noted after using 2 different COVID vaccines – CIDRAP AND Covid vaccines: Mixing increases reports of mild side-effects – BBC
The post RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects. appeared first on Links Medicus.
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications – New England Journal of Medicine
The post Perspective | New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications. appeared first on Links Medicus.
Vaccines seem to work well against coronavirus variants. It’s also complicated – STAT
The post Perspective | Vaccines seem to work well against coronavirus variants. It’s also complicated. appeared first on Links Medicus.
Real-World Effectiveness of Ad26.COV2.S Adenoviral Vector Vaccine for COVID-19 – The Lancet Commentary on Twitter One of the first studies to assess real-world effectiveness of the J&J 1-dose vaccine, matches Phase 3 clinical trial, at 77%https://t.co/3YgcML9YSh @MayoClinic @MayoClinicHS preprint pic.twitter.com/XOjQlUaHK2 — Eric Topol (@EricTopol) May 11, 2021
The post [Preprint] Observational study finds single-dose Johnson & Johnson vaccine is 76.7% effective in preventing SARS-CoV-2 infection appeared first on Links Medicus.
Indonesia study finds China’s Sinovac COVID-19 vaccine effective in medical staff – Reuters
The post [Not published yet] Observational study in Indonesia finds China’s Sinovac COVID-19 vaccine (CoronaVac) was 98% effective at preventing death and 96% effective at preventing hospitalization in healthcare workers appeared first on Links Medicus.
Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine – medRxiv
The post [Preprint] Meta-analysis of risk of vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1-S recombinant vaccine – Overall risk is 1 in 139,000; for age 65 and over, about 1 in 1,000,000; for age under 55, between 1 in 20,000 to 60,000. appeared first on Links Medicus.
Coronavirus variants are spreading in India — what scientists know so far – Nature
The post Coronavirus variants are spreading in India — what scientists know so far. appeared first on Links Medicus.
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial – JAMA (free for a limited period) Commentary on Twitter Among adults with idiopathic pulmonary fibrosis, addition of co-trimoxazole or doxycycline compared with usual care did not significantly improve the time to nonrespiratory hospitalization […]
The post RCT: Among adults with idiopathic pulmonary fibrosis, antimicrobial therapy with co-trimoxazole or doxycycline is not associated with improved outcomes. appeared first on Links Medicus.
Most COVID-19 patients receiving home-based hospital care did not require escalation to traditional hospital setting – American College of Physicians Original study: Factors Associated With Risk for Care Escalation Among Patients With COVID-19 Receiving Home-Based Hospital Care – Annals of Internal Medicine Related: Pandemic Boosts an Old Idea—Bringing Acute Care to the Patient
The post Most COVID-19 patients receiving home-based hospital care did not require escalation to traditional hospital setting – Approximately 1 in 5 were admitted within 14 days. Higher oxygen saturation was associated with decreased odds of transfer, whereas higher comorbidity burden was associated with increased risk. appeared first on Links Medicus.
Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study – The Lancet Infectious Diseases Commentaries: Non-hospitalized COVID-19 patients: Low-risk of serious long-term effects, but more visits to doctor – The Lancet AND Any COVID-19 Infection Raises Odds for Lingering Symptoms, Study Finds – HealthDay AND Those with mild […]
The post Population-based cohort study: Non-hospitalized COVID-19 patients have low-risk of serious long-term effects, but visits to general practitioners and outpatient hospital visits are increased. appeared first on Links Medicus.